122 filings
Page 2 of 7
8-K
jn6bzhv1cx 4yb
25 May 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
4fu jc2z46bi
18 May 23
NanoVibronix Issues Letter to Shareholders
8:30am
8-K
inhmhm jvp
19 Apr 23
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
4:30pm
8-K
9slr kd4qs
28 Mar 23
All functionalities proven to be within testing performance criteria
8:30am
8-K
cdeyga
21 Mar 23
NanoVibronix Files Provisional U.S. Patent Application for UroShield Ultra
8:30am
8-K
qm88hzdq
14 Mar 23
NanoVibronix Announces Positive Results from Independent Product Trial of UroShield for Patients with a Spinal Cord Injury
9:25am
8-K
r45lpv rnrin2ijh
3 Mar 23
Other Events
8:30am
8-K
vn66nmmf
22 Feb 23
NanoVibronix to Launch Rental Program for PainShield and UroShield
8:30am
8-K
vs8y4op853x2c8sr4
8 Feb 23
NanoVibronix Announces Reverse Stock Split
4:30pm
8-K
m840w4i
18 Jan 23
NanoVibronix Provides Update on Expanding Access to PainShield
8:30am
8-K
pho1miqteea vwxka1c
15 Dec 22
Nanovibronix Announces Results of Annual Meeting of Stockholders Held Today
5:29pm
8-K
03gibi29
1 Dec 22
NanoVibronix Announces $2.4 Million Registered
6:06am
8-K
3qgi a7ic3n
29 Nov 22
NanoVibronix Receives FDA 510(k) Premarket Clearance for PainShield Plus
9:13am
8-K
zwonbm7d8h 8c6c8o
16 Nov 22
NanoVibronix Announces Interim Results of Clinical Study for UroShield
8:30am
8-K
1cgz oanc7
19 Oct 22
NanoVibronix Receives Extension to Satisfy Nasdaq Price Requirement
8:30am
8-K
0319uc 8l13yp45caq0
23 Sep 22
NanoVibronix UroShield Approved for Sale through NHS Internal
8:30am
8-K
npwpd keo091ymobo
15 Sep 22
Nanovibronix Sets Date for Annual Shareholder Meeting
9:30am
8-K
g4m4i0rlkgxec5l50h2h
14 Sep 22
NanoVibronix Announces Distribution of Series F Preferred Stock to Holders of its Common Stock
10:21am
8-K
307r2 rz91jnuboq1vo
2 Sep 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
z23armyxmhp9gy7d9vi
2 Sep 22
Other Events
4:30pm